ALXO Alx Oncology Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ALXO

Price (delayed)

$1.94

Market cap

$268.26M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.13

Enterprise value

$255.28M

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 86
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 10
Highlights
The quick ratio has surged by 122% year-on-year and by 35% since the previous quarter
The EPS is up by 48% year-on-year and by 24% since the previous quarter
Alx Oncology Holdings's equity has surged by 111% YoY but it has decreased by 10% QoQ
The debt has grown by 14% since the previous quarter but it has declined by 3.3% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.alxoncology.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ALXO

ALXO stock price

How has the Alx Oncology Holdings stock price performed over time
Intraday
-3.48%
1 week
-8.06%
1 month
-1.52%
1 year
193.67%
YTD
71.68%
QTD
-6.28%

Financial performance

How have Alx Oncology Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$82.55M
Net income
-$80.89M
Gross margin
N/A
Net margin
N/A
ALXO's operating income is up by 32% YoY and by 9% QoQ
ALXO's net income is up by 31% year-on-year and by 9% since the previous quarter

Price vs fundamentals

How does ALXO's price correlate with its fundamentals

Growth

What is Alx Oncology Holdings's growth rate over time

Valuation

What is Alx Oncology Holdings stock price valuation
P/E
N/A
P/B
1.92
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 48% year-on-year and by 24% since the previous quarter
Alx Oncology Holdings's equity has surged by 111% YoY but it has decreased by 10% QoQ
The price to book (P/B) is 9% less than the last 4 quarters average of 2.1 and 4% less than the 5-year quarterly average of 2.0

Efficiency

How efficient is Alx Oncology Holdings business performance
ALXO's return on invested capital is up by 27% since the previous quarter and by 12% year-on-year
ALXO's return on equity is up by 27% since the previous quarter and by 22% year-on-year
The return on assets is up by 21% since the previous quarter and by 21% year-on-year

Dividends

What is ALXO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALXO.

Financial health

How did Alx Oncology Holdings financials performed over time
The quick ratio has surged by 122% year-on-year and by 35% since the previous quarter
Alx Oncology Holdings's current ratio has soared by 115% YoY and by 35% from the previous quarter
The debt is 93% smaller than the equity
Alx Oncology Holdings's equity has surged by 111% YoY but it has decreased by 10% QoQ
Alx Oncology Holdings's debt to equity has plunged by 56% YoY but it has increased by 17% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.